Related Experiment Videos
Subtype selective binding properties of substituted linear melanocyte stimulating hormone analogues
Helgi B Schiöth1, Aster Tesfaye, Felikss Mutulis
1Department of Neuroscience, Biomedical Center, Uppsala University, Box 593, Uppsala 751 24, Sweden. helgis@bmc.uu.se
Neuropeptides
|January 1, 2003
Summary
Researchers synthesized novel melanocortin-stimulating hormone (MSH) analogues to study their binding to melanocortin receptors (MC1-5). Key amino acid substitutions reveal specific binding requirements for MC receptor subtypes, aiding future drug design.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Melanocortin receptors (MC) are G-protein coupled receptors involved in critical physiological processes.
- These receptors regulate energy balance, inflammation, and reproduction.
Purpose of the Study:
- To synthesize and characterize novel linear MSH analogues.
- To investigate the binding affinities of these analogues to human MC receptor subtypes (MC1, MC3, MC4, MC5).
Main Methods:
- Synthesis of 11 new linear MSH analogues.
- Testing of analogue binding to human MC receptors expressed in COS cells.
Main Results:
- Aspartic acid at position 4 differentially affected binding across MC1, MC4, MC5, and MC3 receptors.
- Arginine at position 5 showed high affinity for MC4 receptors.
- Histidine at position 6 is crucial for MC1 receptor binding.
- Aspartic acid at position 10, mimicking gamma-MSH, reduced MC3 and MC4 receptor affinity, indicating conformational differences.
Conclusions:
- Specific amino acid residues in MSH peptides have differential effects on MC receptor subtype binding.
- Understanding these ligand-binding requirements is vital for developing targeted MC receptor modulators.
- The findings support further computational modeling of MC receptor binders.